OTHER CANCER
Clinical trials for OTHER CANCER explained in plain language.
Never miss a new study
Get alerted when new OTHER CANCER trials appear
Sign up with your email to follow new studies for OTHER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare cancer mutation in 300-patient trial
Disease control Recruiting nowThis study tests a new drug called PC14586 (rezatapopt) in people with advanced or spreading solid tumors that have a specific change in the TP53 gene (Y220C mutation). The goal is to see if the drug is safe and works against these cancers. About 300 adults (and some teens after …
Matched conditions: OTHER CANCER
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Scientists hunt for hidden genes behind rare tumors
Knowledge-focused Recruiting nowThis study aims to find the genes that cause pheochromocytoma and paraganglioma, rare tumors of the nervous system. Researchers will analyze DNA from up to 2,000 patients and their family members to link specific genetic changes to tumor development. The goal is to improve geneti…
Matched conditions: OTHER CANCER
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC